60
Participants
Start Date
January 10, 2024
Primary Completion Date
April 10, 2024
Study Completion Date
May 31, 2024
Dexamethasone, tobramycin, netilimicin
Group A: Dexathalm single dose Group B: Tobradex Group C: Dexathalm multi-dose
KasrAl Ainy Hospital, Cairo
Kasr El Aini Hospital
OTHER